Mon.Jan 13, 2020

Disrupting Space: A new event from TechCrunch

TechCrunch LA

Every radical turn in technology history has its great entrepreneur, and for space that person is SpaceX founder Elon Musk.

7 Personal Attributes That Attract Investor Attention

Startup Professionals Musings

As a startup mentor, I’m always amazed that some entrepreneurs seem to be an immediate hit with investors, while others struggle to get any attention at all. Finally I realized that venture capital and angel investors are actually humans, despite some views to the contrary.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bonfire Ventures Looks To Raise New, $100M Fund


Los Angeles-based venture capital investment fund Bonfire Ventures is looking to raise a new, $100M investment fund, Bonfire Ventures II, L.P., according to a regulatory filing by the firm. According to the filing, the managing directors of the new fund are Jim Andelman, Mark Mullen, and Brett Queener. As expected, no details on the fundraising have been announced or mentioned by the firm.

Google 100

Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive


Daré Bioscience launched in 2015 with the aim of assembling a portfolio of novel women’s health products intended to pique interest from major pharmaceutical companies.

Can You Ask for Office Rent Relief? How to Manage Your Lease During COVID-19

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

InTouch Health Acquired For $600M


Santa Barbara-based InTouch Health , which provides telehealth services and robotic, healthcare products, has been acquired by Teladoc Health , for $600M in a combination of cash and stock, the companies said over the weekend. According to the two, the deal is includes approximately $150M in cash and $450M of Teladoc Health common stock.

NeoGenomics Nabs Human Longevity’s Oncology Division for $37M


The genetic testing company NeoGenomics has acquired Human Longevity’s Oncology Division, which provides next-generation sequencing services.

More Trending

Fifth Wall Ventures Raises Around $3.5M In SPV


Venice, California-based venture investor Fifth Wall Ventures , which invests in real estate technology, has raised nearly $3.5M in a Special Purpose Vehicle (SPV)--like as part of an investment in another company--according to a regulatory filing from the firm this morning. Fifth Wall Ventures SPV XIX, L.P., is one of a large set of SPVs the firm has created for various investments. Accoridng to the filing, the firm raised $3,459,250 from 8 inestors in the SPV.

Venice 100

Cognitive Medical Systems Names New CEO


San Diego-based Cognitive Medical Systems , which provides services to public and private organizations services in the area of clinical healthcare delivery, informatics, UI/UX, human factors engineering and enterprise software development, said last week that it has named Christina Murphy as its CEO. Murphy is a bio-pharma executive who also previously had served as a U.S. Marine Corps Colonel.

Saviynt Names New Chief Revenue Officer


Los Angeles-based identity and access management software developer Saviynt announced this morning that it has named Todd Rotger as the company's new Chief Revenue Officer. Rotger was previously at ServiceNow, where he was serving as Vice President of Global Sales, Security and Risk. Rotger also had served as VP of Sales U.S. East at Hewlett Packard Enterprise. Saviynt is led by CEO Amit Saha. The company says it now has more than 400 employees. READ MORE>>.

Sales 100

Human Longevity Sells Off Division For $37M


San Diego-based precision health analytics developer Human Longevity announced this morning that it has sold off its Oncology Division to NeoGenomics , in a deal worth $37M in cash. According to Human Longevity, the deal will help it focus entirely on "longevity and extending the healthy, high-performance human lifespan". The deal closed on Friday. Human Longevity's backers include Celgene, GE, and Illumina.